hrp0098p3-89 | Fat, Metabolism and Obesity | ESPE2024
Zou Chaochun
, Gao Ying
, Yang Lili
, Dai Yangli
, Shen Zheng
, Zhou Qiong
Background: Prader-Willi syndrome (PWS) is a rare and multisystemic genetic disorder that is characterized by severe hypotonia, hyperphagia, short stature, and global developmental delay. Although early recombinant human growth hormone (rhGH) treatment has been proven to rescue some symptoms and bring additional benefits to PWS patients, studies in patients under 2 years old are scarce. Thus, this study aims to investigate the effectiveness and safety of rhGH ...